Epidemiological challenges of COVID-19 in France and in Germany

Epidemiological challenges of COVID-19 in France and in Germany

Online seminar, June 18th, 10h (CET)
  • Actualité Sciences PoActualité Sciences Po

Online seminar, Friday June 18th 2021, 10h (CET)

Mandatory registration 

In spring 2020 the covid-19 pandemic hit Europe. Initially Germany did very well thanks to its epidemiological crisis management, in comparison with several of its European neighbors, France included. But, during the so-called second wave of the pandemic, while the situation was getting better in France, the number of COVID-19 cases (infections and deaths) was increasing in Germany so much, so that by the third wave, both countries faced similar epidemiological challenges.

15 months after COVID-19 patient 0 in France and Germany, respectively on 25th and 28th January 2020, we are still facing and challenging the pandemic. What went wrong? What are the current challenges? What about the „COVID-0-Strategy“ or how can we do better?

German and french epidemiologists and the Laboratory for Interdisciplinary Evaluation of Public Policies (LIEPP), on behalf of the Alfred Grosser-Program of Science Po, will present and try to answer these questions from an epidemiological perspective, so that the EU and its Member States can learn for the future.


  • Aissa Halidou: Professor for Health Policy and Global Health for the Alfred Grosser Chair of Sciences Po and research associate at the Laboratory for Interdisciplinary Evaluation of public policies (LIEPP).


  • Antoine Flahault: Professor of Public Health at the University of Geneva (Switzerland). Director of the Institute of global health. Deputy-Director of the Swiss School of Public Health, Zürich.
  • Arnaud Fontanet: Professor at Institut Pasteur and the „Conservatoire National des Arts et Métiers“. Member of the Scientific Council on the COVID-19 crisis (Conseil Scientifique sur la crise COVID-19) advising the French government.
  • Ralf Reintjes: Professor for Epidemiology and Surveillance at Hamburg University of Applied Sciences (Germany), and for Infectious Disease Epidemiology at Tampere University (Finland) & consultant for the WHO and the EU. Member of the Covid-19 Task force of the Association of Schools of Public Health in the European Region (ASPHER).
  • Wolfgang Hoffmann: Professor for Population-based Epidemiology of Health Care and Community Health. Managing Director of the Institute for Community Medicine at the University Medicine Greifswald (Germany). Co-founder of the Germany Association of Epidemilogy (DGEpi) and Member of the Committee on Health Reporting and Health Monitoring (Kommission“Gesundheitsberichterstattung und Gesundheitsmonitoring”) at the Robert Koch Institute (RKI) in Berlin.

See the previous seminar on this topic organized by Aissa Halidou 

Back to top